ICD10monitor February 15, 2023
The program aims to lower drug costs and improve affordability for Americans with Medicare.
The Centers for Medicare & Medicaid Services (CMS) has released initial guidance on the Medicare Prescription Drug Inflation Rebate Program, and is seeking public comment on key topics, including how to determine the number of drug units for rebate-able drugs, reducing rebate amounts for certain Part B and Part D rebate-able drugs in cases of supply shortages or disruptions, imposing civil monetary penalties on manufacturers that fail to pay rebates, ensuring accuracy of rebate payments, and other related areas. The public’s input will help shape the program’s final regulations and implementation.
The new Program will require drug companies to pay rebates to the Medicare Trust Fund...
Today's Sponsors
Today's Sponsor